StockNews.com initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. Cancer Genetics Trading Down 2.3 % Cancer Genetics stock opened at $4.61 on Friday. Cancer Genetics has a twelve month low of $2.11 and a twelve month high […]
Related Keywords
, Vyant Bio Inc , Cancer Genetics , Free Report , Genetics Trading Down , Get Free Report , Rett Syndrome , Cancer Genetics Daily , Nasdaq Cgix , Cgix , Health Care And Social Assistance , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.